During the past decade, St. Marien Hospital - Muelheim an der Ruhr conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St. Marien Hospital - Muelheim an der Ruhr" are "Lymphoma" (2 trials). Many other conditions were trialed in "St. Marien Hospital - Muelheim an der Ruhr" in a lesser frequency.

Most popular intervention types in "St. Marien Hospital - Muelheim an der Ruhr" are "Biological" (2 trials), "Drug" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials), "filgrastim" (2 trials), "prednisone" (2 trials) and "radiation therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Marien Hospital - Muelheim an der Ruhr" are 2 trials for "All" genders.

Currently, there are NaN active trials in "St. Marien Hospital - Muelheim an der Ruhr". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in St. Marien Hospital - Muelheim an der Ruhr, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Marien Hospital - Muelheim an der Ruhr, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".